145 related articles for article (PubMed ID: 9305383)
1. Cytologic study of ascites and the endometrium in ovarian carcinoma. Clinical significance.
Hirasawa T; Yasuda M; Muramatsu T; Itoh H; Shinozuka T; Makino T; Tsutsumi Y; Osamura RY
Acta Cytol; 1997; 41(5):1451-5. PubMed ID: 9305383
[TBL] [Abstract][Full Text] [Related]
2. Cervicovaginal and endometrial cytology in ovarian cancer.
Takashina T; Ono M; Kanda Y; Sagae S; Hayakawa O; Ito E
Acta Cytol; 1988; 32(2):159-62. PubMed ID: 3348057
[TBL] [Abstract][Full Text] [Related]
3. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
4. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
5. Identification of intranuclear inclusions is useful for the cytological diagnosis of ovarian clear cell carcinoma.
Naka M; Ohishi Y; Kaku T; Watanabe S; Tamiya S; Ookubo F; Kato K; Oda Y; Sugishima S
Diagn Cytopathol; 2015 Nov; 43(11):879-84. PubMed ID: 26219930
[TBL] [Abstract][Full Text] [Related]
6. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
Morency E; Leitao MM; Soslow RA
Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of endometrial aspiration cytology for the preoperative diagnosis of ovarian carcinoma.
Jobo T; Arai M; Iwaya H; Kato Y; Ohno E; Kuramoto H
Acta Cytol; 1999; 43(2):104-9. PubMed ID: 10097693
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
9. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer.
Kodama J; Miyagi Y; Seki N; Tokumo K; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):107-10. PubMed ID: 10192497
[TBL] [Abstract][Full Text] [Related]
10. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015.
Krugmann J; Schwarz CL; Melcher B; Sterlacci W; Ozalinskaite A; Lermann J; Agaimy A; Vieth M
Arch Gynecol Obstet; 2019 Feb; 299(2):515-523. PubMed ID: 30415435
[TBL] [Abstract][Full Text] [Related]
11. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
Mutch DG; Prat J
Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
[No Abstract] [Full Text] [Related]
12. B7-H4 overexpression in ovarian tumors.
Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
[TBL] [Abstract][Full Text] [Related]
13. [Pathology of ovarian cancer].
Kaku T; Watanabe S; Ohishi Y
Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
[No Abstract] [Full Text] [Related]
14. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary.
Davis M; Rauh-Hain JA; Andrade C; Boruta DM; Schorge JO; Horowitz NS; May T; del Carmen MG
Gynecol Oncol; 2014 Mar; 132(3):760-6. PubMed ID: 24440832
[TBL] [Abstract][Full Text] [Related]
15. Cytological features of cervical smears in serous adenocarcinoma of the endometrium.
Todo Y; Minobe S; Okamoto K; Takeda M; Ebina Y; Watari H; Terashima M; Kaneuchi M; Yamamoto R; Sakuragi N
Jpn J Clin Oncol; 2003 Dec; 33(12):636-41. PubMed ID: 14769842
[TBL] [Abstract][Full Text] [Related]
16. Endometrial aspiration cytology for diagnosis of peritoneal lesions in extrauterine malignancies.
Saji H; Kurose K; Sugiura K; Miyagi E; Onose R; Kato H; Nakayama H
Acta Cytol; 2007; 51(4):533-40. PubMed ID: 17718117
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.
Hoang LN; Han G; McConechy M; Lau S; Chow C; Gilks CB; Huntsman DG; Köbel M; Lee CH
Histopathology; 2014 Mar; 64(4):585-96. PubMed ID: 24103020
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
[TBL] [Abstract][Full Text] [Related]
19. Prognostic analysis of ovarian cancer associated with endometriosis.
Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
[TBL] [Abstract][Full Text] [Related]
20. [Expression of folate receptor alpha in ovarian epithelial tumors].
Shen DH; Xie JL; Zhang YL; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):747-51. PubMed ID: 21215165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
